Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
319.7 INR | -0.05% | -2.74% | -18.91% |
16/05 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
16/05 | Transcript : Indoco Remedies Limited, Q4 2024 Earnings Call, May 16, 2024 |
Business Summary
Number of employees: 6,000
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
94.6
%
| 14,160 | 91.9 % | 15,779 | 94.6 % | +11.44% |
Services
3.7
%
| 878 | 5.7 % | 622 | 3.7 % | -29.18% |
Exchange Gain/(Loss) (Net) (Other than Considered in Finance Cost)
1.2
%
| 332 | 2.2 % | 205 | 1.2 % | -38.16% |
Export Incentives
0.4
%
| 32 | 0.2 % | 74 | 0.4 % | +134.24% |
Scrap
0.0
%
| 7 | 0.0 % | 6 | 0.0 % | -2.94% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 15,408 | 100.0 % | 16,686 | 100.0 % | +8.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 27/04/27 | |
Pramod Ghorpade
DFI | Director of Finance/CFO | - | 02/21/02 |
Chairman | 85 | 02/63/02 | |
Compliance Officer | - | 01/15/01 | |
Kavita lnamdar
CTO | Chief Tech/Sci/R&D Officer | 57 | 08/10/08 |
Director/Board Member | 63 | 01/82/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 85 | 02/63/02 | |
Director/Board Member | 63 | 01/82/01 | |
Chief Executive Officer | 54 | 27/04/27 | |
Director/Board Member | 65 | 28/14/28 | |
Director/Board Member | 71 | 27/20/27 | |
Director/Board Member | 59 | 03/20/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 92,182,205 | 31,547,407 ( 34.22 %) | 0 | 34.22 % |
Company contact information
Indoco Remedies Ltd.
Indoco House, Santacruz East 166 CST Road
400098, Mumbai
+91 22 6287 1000
http://www.indoco.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.07% | 694B | |
+29.39% | 593B | |
-1.49% | 371B | |
+19.96% | 331B | |
+7.25% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.48% | 169B |
- Stock Market
- Equities
- INDOCO Stock
- INDOCO Stock
- Company Indoco Remedies Limited